These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6691458)

  • 21. Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia.
    Baron M; Levitt M; Gruen R; Kane J; Asnis L
    Am J Psychiatry; 1984 Jul; 141(7):836-42. PubMed ID: 6731631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.
    Weinshilboum RM; Raymond FA
    Am J Hum Genet; 1977 Mar; 29(2):125-35. PubMed ID: 848488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia.
    Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E
    Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catechol-o-methyltransferase activity in erythrocytes in Down's syndrome: family studies.
    Gustavson KH; Flodérus Y; Jagell S; Wetterberg L; Ross SB
    Clin Genet; 1982 Jul; 22(1):22-4. PubMed ID: 6216990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte catechol-O-methyltransferase activity: genetic analysis in nuclear families with one child affected by Down syndrome.
    Brahe C; Serra A; Morton NE
    Am J Med Genet; 1985 Jun; 21(2):373-84. PubMed ID: 3160238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance.
    Karege F; Bovier P; Gaillard JM; Tissot R
    Acta Psychiatr Scand; 1987 Sep; 76(3):303-8. PubMed ID: 3478963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia.
    Matsumoto M; Weickert CS; Beltaifa S; Kolachana B; Chen J; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
    Neuropsychopharmacology; 2003 Aug; 28(8):1521-30. PubMed ID: 12799619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
    Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
    J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.
    Chen X; Wang X; O'Neill AF; Walsh D; Kendler KS
    Mol Psychiatry; 2004 Oct; 9(10):962-7. PubMed ID: 15124004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity.
    Kotler M; Barak P; Cohen H; Averbuch IE; Grinshpoon A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Dec; 88(6):628-33. PubMed ID: 10581481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
    Lopez-Garcia P; Young Espinoza L; Molero Santos P; Marin J; Ortuño Sanchez-Pedreño F
    Psychiatry Res; 2013 Jul; 208(2):118-24. PubMed ID: 23102922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catechol-O-methyltransferase activity in erythrocytes from patients with eating disorders.
    Amorim-Barbosa T; Serrão MP; Brandão I; Vieira-Coelho MA
    Eat Weight Disord; 2016 Jun; 21(2):221-7. PubMed ID: 26296436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection.
    Schultz E; Nissinen E; Kaakkola S
    Biomed Chromatogr; 1989 Mar; 3(2):64-7. PubMed ID: 2736320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity.
    Scanlon PD; Raymond FA; Weinshilboum RM
    Science; 1979 Jan; 203(4375):63-5. PubMed ID: 758679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of erythrocyte catechol-O-methyltransferase activity as a possible marker for vulnerability of affective disorder.
    Dunner DL
    Psychopharmacol Bull; 1979 Jan; 15(1):32. PubMed ID: 419244
    [No Abstract]   [Full Text] [Related]  

  • 39. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.
    Tunbridge EM; Harrison PJ; Weinberger DR
    Biol Psychiatry; 2006 Jul; 60(2):141-51. PubMed ID: 16476412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia.
    Baron M; Gruen R; Rainer JD; Kane J; Asnis L; Lord S
    Am J Psychiatry; 1985 Apr; 142(4):447-55. PubMed ID: 3976917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.